Evidence map›Paper›PMID 31883055›Full record

ArticleNeurochemical research2020

Prolonged Amphetamine Treatments Cause Long-Term Decrease of Dopamine Uptake in Cultured Cells.

Nafisa Ferdous, Sirisha Kudumala, Serena Sossi, Lucia Carvelli

Open access · hybridAbstract read
In one paragraph

Article in Neurochemical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nafisa FerdousDepartment of Biomedical Science, University of North Dakota, Grand Forks, ND, USA.
Sirisha KudumalaHarriet L. Wilkes Honors College, Florida Atlantic University, FL, Jupiter, USA.
Serena SossiIntegrated Biology Program, Florida Atlantic University, FL, Boca Raton, USA.
Lucia CarvelliBrain Institute, Florida Atlantic University, Jupiter, FL, USA. lcarvelli@fau.edu.ORCID http://orcid.org/0000-0001-8754-3777
Florida Atlantic University · USUniversity of North Dakota · US

Funding

Amphetamine causes transgenerational effectsR01DA042156 · NIDA · UNIVERSITY OF NORTH DAKOTA · PI CARVELLI, LUCIA · 2016 to 2020
$1.7M
NIDA NIH HHS DA042156NIDA NIH HHS R01 DA042156
6 · The paper itself

Abstract

Amphetamine (AMPH) is a systemic stimulant used to treat a variety of diseases including Attention Deficit Hyperactive Disorder, narcolepsy and obesity. Previous data showed that by binding to catecholamine transporters, AMPH prevents the reuptake of the neurotransmitters dopamine (DA) and norepinephrine (NE). Because AMPH, either used therapeutically at final concentrations of 1-10 µM or abused as recreational drug (50-200 µM), is taken over long periods of time, we investigated the prolonged effects of this drug on the uptake of DA. We found that, in LLC-PK1 cells stably expressing the human DA transporter (hDAT), pretreatments with 1 or 50 µM AMPH caused significant reduction in DA uptake right after the 15-h pretreatment. Remarkably, after 50 but not 1 µM AMPH pretreatment, we observed a significant reduction in DA uptake also after one, two or three cell divisions. To test whether these long-term effects induced by AMPH where conserved in a model comparable to primordial neuronal cells and native neurons, we used the human neuroblastoma cell line SH-SY5Y cells, which were reported to endogenously express both hDAT and the NE transporter. Pretreatments with 50 µM AMPH caused a significant reduction of DA uptake both right after 15 h and 3 cell divisions followed by neuro-differentiation with retinoic acid (RA) for 5 days. Under these same conditions, AMPH did not change the intracellular concentrations of ATP, ROS and cell viability suggesting, therefore, that the reduction in DA uptake was not cause by AMPH-induced toxicity. Interestingly, while 1 µM AMPH did not cause long-term effects in the LLC-PK1 cells, in the SH-SY5Y cells, it decreased the DA uptake after one, two, but not three, cell divisions and 5-day RA differentiation. These data show that besides the well-known acute effects, AMPH can also produce long-term effects in vitro that are maintained during cell division and transmitted to the daughter cells.

Indexed as

AmphetamineAnimalsCell Line, TumorCells, CulturedDopamineDopamine Uptake InhibitorsDose-Response Relationship, DrugDrug Administration ScheduleHumansLLC-PK1 CellsReactive Oxygen SpeciesSwineTime FactorsAmphetamineDopamineDopamine Uptake InhibitorsReactive Oxygen Species

Identifiers

PMID31883055
PMCPMC7260268
OpenAlexW2996765896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.